Squarepoint’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.19M Sell
134,221
-131,864
-50% -$1.17M ﹤0.01% 1431
2025
Q1
$2.08M Buy
266,085
+138,496
+109% +$1.08M ﹤0.01% 1144
2024
Q4
$1.34M Sell
127,589
-1,026
-0.8% -$10.8K ﹤0.01% 1369
2024
Q3
$1.69M Buy
+128,615
New +$1.69M ﹤0.01% 1197
2023
Q4
Sell
-14,582
Closed -$150K 2499
2023
Q3
$150K Buy
+14,582
New +$150K ﹤0.01% 2183
2021
Q3
Sell
-28,162
Closed -$190K 2229
2021
Q2
$190K Buy
28,162
+16,194
+135% +$109K ﹤0.01% 2253
2021
Q1
$108K Sell
11,968
-44,698
-79% -$403K ﹤0.01% 2341
2020
Q4
$379K Sell
56,666
-4,499
-7% -$30.1K ﹤0.01% 1699
2020
Q3
$308K Buy
+61,165
New +$308K ﹤0.01% 1655